Dyadic International vs Xenetic Biosciences
Dyadic International and Xenetic Biosciences are similar in size: $3.1m and $3.0m of revenue in their latest fiscal years. Xenetic Biosciences grew faster (19.0% against -11.6%). Xenetic Biosciences kept more of each dollar of sales as profit: a net margin of -90.1% against -238.3%.
| Latest fiscal year | Dyadic InternationalDYAI, 2025 | Xenetic BiosciencesXBIO, 2025 |
|---|---|---|
| Revenue | $3.1m | $3.0m |
| Revenue growth | -11.6% | 19.0% |
| Net income | −$7.4m | −$2.7m |
| Operating margin | -232.8% | — |
| Net margin | -238.3% | -90.1% |
| Return on equity | — | -40.0% |
| Free cash flow | — | −$2.3m |
| Cash | $4.6m | $7.9m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 5 | — |
| Market value | $13.2m | $5.0m |
| Price vs our value range | — | — |
| Moat score | 8 (Weak) | 8 (Weak) |
| Insider trades, 12 months | 0 buys, 3 sales | 0 buys, 0 sales |